Prior Arts Survey
http://opm.phar.umich.edu/species.php?species=Borrelia%20burgdorferi
This database contains the structure and information on OspC protein of Borrelia burgdorferi
http://borreliabase.org/
This database contains multiple DNA sequences of the strains.
http://www.lyme-disease-research-database.com/
Database of technical papers on lyme disease.
http://biopython.org/
I will be using biopython to design my website
https://www.ncbi.nlm.nih.gov/pmc/
I get my information from PubMed papers
http://www.sciencedirect.com/
I get my information from technical papers on science direct along with PubMed
In order to figure out what a patent currently exists for, I first needed to figure out the different parts of my project that would be patentable. So first, a database on lyme disease related things. There are only 3 that exist and both are listed above, neither of them cover the territory that my database will. Second would be the sequences or the strains that I am collecting. According to a recent supreme court decision, sequences that exist in nature cannot be patented but sequences that are edited and are not found in nature can be patented. This will not be an issue for me because I am only using the natural genomes of Borrelia. Next in terms of patenting strains, you can only patent a strain if it does not exist in nature and you genetically engineered it. I will not be dealing with any genetically engineered strains. Nor am I creating any sort of lyme disease strains therefore a patent search in order to avoid infringing on someone else's patent would be pointless. I will be coding in a language that is free to public use and if I decide to use Matlab, we have paid for a years subscription so that won't be an issue. I looked through about 25 patents under the input bioinformatics lyme disease as well as database lyme disease and nothing that would overlap with my research came up. Most patents under that search were patenting a antibody which would detect lyme disease proteins in a western blot or a new type of antibiotic. I am not creating anything, only compiling existing data that is already available to the public so I do not see any part of my project that would infringe upon a patent.
Literature Survey
https://www.ncbi.nlm.nih.gov/pubmed/27588694
FlgE is a protein involved in the Borrelia hooking onto cells.
https://www.ncbi.nlm.nih.gov/pubmed/26480895
BbHtrA is a protease within Borrelia burgdorferi.
https://www.ncbi.nlm.nih.gov/pubmed/26438793
OspC is an outer surface protein on Bb which prevents it from being eaten by phagocytes.
https://www.ncbi.nlm.nih.gov/pubmed/26953324
OspA and OspB are both outer surface proteins on Bb and help it evade the immune system
https://www.ncbi.nlm.nih.gov/pubmed/27502325
Ip28-1 plasmid is responsible for the variation in the VIsE lipoprotien that helps Bb evade the immune system.
https://www.ncbi.nlm.nih.gov/pubmed/27161310
A variant of TP0435 lipoprotein which was thought to be found only within Treponema pallidum is found within Borrelia Burgdorferi and it allows the bacteria to adhere to a host cell.
https://www.ncbi.nlm.nih.gov/pubmed/26808924
BBK32 is another lipoprotein which blocks the recruitment of molecules within the complement system
https://www.ncbi.nlm.nih.gov/pubmed/26434356
BGA66 and BGA71 are both outer surface proteins which inhibit the complement system, the alternative pathway and the classical pathway.
https://www.ncbi.nlm.nih.gov/pubmed/26247174
Lmp1 aids in the adhesion of Bb to the host cell and allows the persistence of infection.
https://www.ncbi.nlm.nih.gov/pubmed/26181365
BAPKO_0422 is a protein that binds to the human factor H and inhibits the complement system.
https://www.ncbi.nlm.nih.gov/pubmed/24191298
CspA binds to human factor H and inhibits the complement system.
https://www.ncbi.nlm.nih.gov/pubmed/27725820
CspZ, ErpA, ErpC, ErpP, and p43 are all surface proteins that allow Bb to evade the immune system. Varient of CD59 binds to human factor H to inhibit complement system.
https://www.ncbi.nlm.nih.gov/pubmed/24702793
CspZ binds to CFH and CFHL-1 to inhibit complement system. CspZ is one of the 5 proteins that Bb creates that binds to CFH and CFHL-1.
https://www.ncbi.nlm.nih.gov/pubmed/25582082
ErpA, ErpC, ErpP all bind to CFH and CFHL-1 however ErpC may only bind to CFHR and not CFH.
https://www.ncbi.nlm.nih.gov/pubmed/20022381
CRASP-1/Bba68 works with OspE to bind to factor A and inhibit complement system.
https://www.ncbi.nlm.nih.gov/pubmed/14629271
p39, p41 in IgM IB, and p83/100, p39, Osp17 in IgG IB; in late LB: p39, p41 in IgM IB, and p83/100, Osp17, p21 and p43 in IgG IB are all proteins that can be detected at different stages during a lyme disease infection.
https://www.ncbi.nlm.nih.gov/pubmed/11599789
Osp17 and OspC actually induce a humoral immune response
https://www.ncbi.nlm.nih.gov/pubmed/19451251
CspA a surface lipoprotein binds to FH/FH-1 (human factor H and H like protein) and allows Borrelia to evade the immune system in an unknown manner. FH aids in the immune system by binding to defect human cells and marking them for destruction.
Borrelia Burgdoferi evades the immune system by preventing certain pathways of the immune response to work. It inhibits the complement system by creating proteins that bind to the human factor H as well as CHF and CHFL-1. These prevent the complement system from from recruiting other proteins to fight the infection. The proteins that bind to human factor H are a variant of CD59, variant of TP0435, BBK32, BGA66,
BAPKO_0422, CspA and BGA71. Other proteins aid in the adhesion of the bacteria to the host cell, these include: Lmp, FlgE. The detection of lyme disease is different depending on how far the infection has progressed. In the earliest stages
p39, p41 in IgM IB, and p83/100, p39, Osp17 in IgG IB. In late LB: p39, p41 in IgM IB, and p83/100, Osp17, p21 and p43 in IgG IB. It is crucial that we understand what proteins to detect at different stages so that we can have the most accurate test to see whether or not you have lyme disease. The current test is only 50% accurate. Knowing which proteins are present at which stages and which proteins do what will help researchers find better ways to treat and diagnose lyme disease.